ArticleActa pharmacologica Sinica2017

Preclinical evaluation of the efficacy, pharmacokinetics and immunogenicity of JS-001, a programmed cell death protein-1 (PD-1) monoclonal antibody.

Jie Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.